|
| Status |
Public on Jan 30, 2015 |
| Title |
Top2a identifies and provides epigenetic rationale for novel combination therapeutic strategies for aggressive prostate cancer |
| Organism |
Mus musculus |
| Experiment type |
Expression profiling by high throughput sequencing
|
| Summary |
We perform RNA-seq on matched orthotopic murine primary and metastatic prostate cancer samples to identify differential gene expressions
|
| |
|
| Overall design |
RNA-seq was performed on orthotopic murine primary and metastatic tumor samples using Illumina Hi-Seq 2000 platform
|
| |
|
| Contributor(s) |
Ellis L, Wang J, Hu Q |
| Citation(s) |
25605014 |
| Submission date |
Jan 07, 2015 |
| Last update date |
May 15, 2019 |
| Contact name |
Qiang Hu |
| E-mail(s) |
Qiang.Hu@RoswellPark.org
|
| Organization name |
Roswell Park Cancer Institute
|
| Street address |
Elm & Carlton Streets
|
| City |
Buffalo |
| State/province |
NY |
| ZIP/Postal code |
14263 |
| Country |
USA |
| |
|
| Platforms (1) |
| GPL13112 |
Illumina HiSeq 2000 (Mus musculus) |
|
| Samples (8)
|
| GSM1580362 |
Androgen Sensitive Primary Orthotopic Tumor (RS-01574309) |
| GSM1580363 |
Androgen Sensitive Met (matched) (RS-01574310) |
| GSM1580364 |
Androgen Sensitive Primary Orthotopic Tumor (RS-01574311) |
| GSM1580365 |
Androgen Sensitive Met (matched) (RS-01574312) |
| GSM1580366 |
Castrate Resistant Primary Orthotopic Tumor (RS-01580057) |
| GSM1580367 |
Castrate Resistant Met (matched) (RS-01580058) |
| GSM1580368 |
Castrate Resistant Primary Orthotopic Tumor (RS-01580059) |
| GSM1580369 |
Castrate Resistant Met (matched) (RS-01580060) |
|
| Relations |
| BioProject |
PRJNA271869 |
| SRA |
SRP051814 |
Less...
More...